Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series.
Kendall F MoseleyJarushka NaidooClifton O BinghamMichael A CarducciPatrick M FordeGeoffrey T GibneyEvan J LipsonAmi A ShahWilliam H SharfmanLaura C CappelliPublished in: Journal for immunotherapy of cancer (2018)
This case series represents the first description of potential skeletal adverse effects related to immune checkpoint inhibitors. These findings are important for providers caring for patients who experience musculoskeletal symptoms and may merit additional evaluation.